1405-888X
1405-888X
S1405-888X2021000100206
10.22201/fesz.23958723e.2021.329
Mexico
00
00
2021
00
00
2021
24
[
2005
48
5373-7
]
[
2019
369
311-7
]
[
2011
333
1898-903
]
[
1985
260
7094-101
]
[
2017
56
1077-84
]
[
2003
278
47408-15
]
[
2010
53
4198-211
]
[
2002
277
21453-7
]
[
2007
115
84-105
]
[
2014
5
1313-7
]
[
2004
268
441-7
]
[
2005
118
4605-12
]
[
2015
128
878-87
]
[
2010
33
91-101
]
[
2010
62
579-87
]
[
ClinicalTrials.gov
2017
]
[
2010
6
499-507
]
[
2002
359
1221-31
]
[
2016
7
18-33
]
[
2011
63
409-16
]
[
2005
19
1926-8
]
[
1996
15
791-7
]
[
2012
7
]
[
2004
5
1777-82
]
[
2003
305
70-7
]
[
2012
23
587-99
]
[
Gasperini & Ruggieri
2012
6
175-86
]
[
2012
167
1035-47
]
[
2010
24
4701-10
]
[
2009
325
1254-7
]
[
2012
335
851-5
]
[
1990
4
2881-9
]
[
2008
1781
477-82
]
[
1990
265
9308-13
]
[
2001
276
33697-704
]
[
2005
25
1459-69
]
[
2010
32
414-25
]
[
2008
153
S379-88
]
[
2019
71
267-315
]
[
2015
333
171-7
]
[
2004
55
627-38
]
[
2010
285
7794-804
]
[
2007
282
10690-6
]
[
2004
279
29367-73
]
[
2000
406
192-5
]
[
2001
8
693-704
]
[
2013
75
831-41
]
[
2005
65
3788-95
]
[
2000
106
951-61
]
[
1990
248
1547-50
]
[
2001
14
203-9
]
[
2018
38
1-15
]
[
2004
427
355-60
]
[
2005
25
11113-21
]
[
2013
1843
327-34
]
[
2010
166
132-44
]
[
2012
34
73-91
]
[
2009
14
911-23
]
[
2007
282
9082-9
]
[
2016
13
1-14
]
[
2013
4
333-7
]
[
2013
33
1505-12
]
[
2010
285
14134-43
]
[
2010
9
373-86
]
[
1999
112
3667-75
]
[
2020
23
]
[
2004
94
724-34
]
[
2004
279
13839-48
]
[
2007
120
3905-10
]
[
2016
173
]
[
2005
111
222-9
]
[
2002
277
]
[
2008
1781
483-8
]
[
2008
29
413-20
]
[
1992
70
729-40
]
[
2010
58
1465-76
]
[
2006
3
681-732
]
[
2001
277
5767-77
]
[
2016
354
]
[
2014
3
170-8
]
[
2012
150
780-91
]
[
1999
16
2840-5
]
[
2000
113
183-92
]
[
2004
11
975-83
]